Results 111 to 120 of about 35,214 (259)

Metaproteomics characterizes host-microbiota responses to the time in range derived from continuous glucose monitoring in type 1 diabetes. [PDF]

Chin Med J (Engl)
Zhou L, Xu J, Li S, Deng M, Xiao X, Ma L, Sun H, Liu X, Guo Z, Ding L, Yu R, Liu J, Zhang Q, Xiao X, Sun W.   +14 more
europepmc   +1 more source

Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed‐Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study‐Level Synthesis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Hybrid closed‐loop (HCL) systems achieve rapid, algorithm‐driven improvements in glycaemia in type 1 diabetes (T1D). Paradoxically, rapid improvement in glycaemic control is associated with early worsening of diabetic retinopathy (EWDR), a phenomenon established in the intensive insulin therapy era.
Matthew Anson, Ahmed Iqbal, Shazli Azmi, Philip Weston, Lucy Hughes, Mahreen Choudhury, David M. Hughes, Yalin Zheng, Philip I. Burgess, Uazman Alam   +9 more
wiley   +1 more source

Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Risk Among People With Diabetes: Systematic Scoping Review. [PDF]

JMIR Diabetes
Thomsen HB, Lebiecka-Johansen B, Nørgaard O, Helms Andersen T, Andersen ST, Fagherazzi G, Hulman A, Isaksen AA.   +7 more
europepmc   +1 more source

Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G

Diabetes, Obesity and Metabolism, EarlyView.
Michelantonio De Fano, Rachele Tortoriello, Stefania Rucco, Sofia Corio, Marcello Manco, Edoardo Guerrini, Francesca Porcellati   +6 more
wiley   +1 more source

Real‐World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Automated insulin delivery (AID) systems improve glycaemic outcomes in Type 1 diabetes; however, paediatric real‐world data on newly introduced tubeless AID systems remain limited. We aimed to provide the first clinical evaluation of the A8 TouchCare Nano AID system with the APGO algorithm in children and adolescents with Type 1 diabetes ...
Angela Zanfardino, Dario Iafusco, Giorgia Ippolito, Emanuele Miraglia del Giudice, Assunta Serena Rollato, Antonietta Chianese, Adele Figuccia, Sonia Toni, Annalisa Giulia Ferlito, Barbara Piccini   +9 more
wiley   +1 more source

Long‐Term Associations Between Energy Expenditure and CGM‐Derived Metrics in Adults With Type 1 Diabetes: A Retrospective Analysis of the Syntactiq Cockpit Database

Diabetes, Obesity and Metabolism, EarlyView.
Katharina Bünzel, Sabrina Sanfilippo, Janis Schierbauer, Lukas Schuster, Harald Sourij, Martin Tauschmann, Ulrike Leb‐Stöger, Andreas Seemann, Gerhard Tschakert, Philipp Birnbaumer, Ali Kapan, Othmar Moser   +11 more
wiley   +1 more source

Comparison of Diluted Insulin (U10) Versus Standard (U100) Insulin in Automated Insulin Delivery Systems: Reducing Time Below Range in Young Children

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Treating young children with Type 1 diabetes (CwT1D) is challenging due to their very small need for insulin. We investigated the safety of diluted insulin (U10) in the AID system and how its use affected glycaemic outcomes compared to standard insulin.
Heidi Falk, Ada Aaltio, Mari‐Anne Pulkkinen, Tero Varimo, Anna‐Kaisa Tuomaala   +4 more
wiley   +1 more source

Community pharmacy-led diabetes management using continuous glucose monitoring for suboptimally controlled type 2 diabetes: A pilot feasibility study. [PDF]

PLoS One
Joung KI, Hwang JW, Seo SY, Back KH, Jeon YG, Kim KJ.   +5 more
europepmc   +1 more source

Association of Variability of Monthly Continuous Glucose Monitoring‐Derived Metrics With Diabetic Kidney Disease in Type 1 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background While HbA1c is the standard for monitoring long‐term glycaemic control, it fails to capture glycaemic variability. We investigated the discriminatory capacity of longitudinal continuous glucose monitoring (CGM) metrics and identified CGM metric patterns associated with diabetic kidney disease (DKD) in individuals with type 1 ...
Byeongjae Kang, Rosa Oh, Taeyoung Kim, Jee Hee Yoo, Danbee Kang, Gyuri Kim, Sang‐Man Jin, Myung Jin Chung, Jae Hyeon Kim   +8 more
wiley   +1 more source

Dapagliflozin and linagliptin combination therapy improves time in range and reverses hepatic steatosis in patients with type 2 diabetes and hypertension. [PDF]

Front Endocrinol (Lausanne)
Li W, Li R, Li S, Li Z, Ma J, Wu F, Chen C.   +6 more
europepmc   +1 more source